Form 4 for VABK Virginia National Bankshares Corp
Accepted 2022-11-02 00:00:00 ET · period of report 2022-11-01 · accession 0001209191-22-055387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-02 | 2022-11-01 | VABK | BAYES VIRGINIA R | EVP, Chief Credit Off | A - Grant | $0.00 | +2,500 | 14.6K | +21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-01 | A | A | 2,500 | $0.00 | 14,635.21 | D | — | — | (F1) This restricted stock grant vests in five equal annual installments beginning November 1, 2023. (F2) Includes 160.212 shares acquired by reinvestment of dividends under the Investors Choice Dividend Reinvestment & Direct Stock Purchase and Sale Plan |